Cannabinoid Formulations for Specialized Environments

Publication ID: 24-11857530_0009_PTD
Published: October 28, 2025
Category:Specialized Variations & Niche Solutions

Legal Citation

pr1or.art Inc., “Cannabinoid Formulations for Specialized Environments,” Published Technical Disclosure No. 24-11857530_0009_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857530_0009_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,530.

Summary of the Inventive Concept

The present inventive concept adapts cannabinoid formulations to specific, narrow markets or unique operational environments, addressing the limitations of traditional formulations in high-security, disaster relief, extreme weather, and high-altitude scenarios.

Background and Problem Solved

The original patent disclosed cannabinoid formulations tailored to an individual's genotype. However, these formulations may not be effective or suitable in specialized environments, such as high-security facilities, disaster relief zones, or extreme weather conditions. The present inventive concept addresses these limitations by designing formulations that can adapt to these unique environments, ensuring optimal efficacy and safety.

Detailed Description of the Inventive Concept

The inventive concept comprises a system, method, or kit that integrates genotype-based formulations with environmental factors, security protocols, and user interfaces. For instance, the system for high-security environments includes a database of genotype-based formulations, a security module for verifying user identity and clearance, and a dispensing module for releasing the formulation to an authorized user. The method for disaster relief involves identifying a specific disaster scenario, selecting a formulation based on the scenario, and administering the formulation to affected individuals. The portable kit for extreme weather conditions features a waterproof container, a plurality of formulations tailored to specific weather conditions, and a user interface for selecting a formulation based on current weather data.

Novelty and Inventive Step

The present inventive concept is novel and non-obvious in its adaptation of cannabinoid formulations to specialized environments, incorporating security protocols, environmental sensors, and user interfaces to ensure optimal efficacy and safety. The inventive concept's unique combination of genotype-based formulations, environmental factors, and security protocols provides a significant improvement over traditional formulations.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept may include integrating additional environmental sensors, such as temperature or humidity sensors, or incorporating artificial intelligence to optimize formulation selection. Variations may include adapting the formulations for specific industries, such as healthcare or agriculture, or developing customized formulations for unique operational environments, such as space exploration or underwater operations.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in various industries, including healthcare, agriculture, and disaster relief. The market for cannabinoid formulations is growing rapidly, and the present inventive concept addresses a specific need for specialized formulations in unique operational environments. The target industries include healthcare providers, disaster relief organizations, and government agencies operating in high-security or extreme weather environments.

Field of Art

Pharmaceutical formulations, specifically cannabinoid composition design with emphasis on personalized medicine and environmental adaptation

Person of Ordinary Skill (PHOSITA) Profile

A professional with advanced degrees in pharmaceutical sciences, pharmacology, or chemical engineering, possessing expertise in cannabinoid formulation, drug delivery systems, and personalized medicine techniques

Obviousness Rationale

A PHOSITA would recognize that adapting cannabinoid formulations to specific environments and user characteristics is a natural extension of the source patent's genotype-based approach. The disclosed variations represent predictable applications of known cannabinoid composition principles, utilizing standard techniques of modifying ratios, adding environmental sensors, and implementing security protocols. The PTD's claims represent logical combinations of existing cannabinoid formulation strategies with known technological integration methods.

Obvious Combinations & Variations

Source Patent Element
Cannabinoid formulation with specific CBD:THC ratios and terpene profiles
PTD Variation
Customizing formulations for high-altitude environments with adjusted CBD:THC ratios
Obviousness Reasoning
A PHOSITA would recognize that altitude affects physiological responses, making ratio adjustments a predictable design optimization using known pharmacological principles
Source Patent Element
Genotype-based cannabinoid formulations
PTD Variation
Integrating security modules and user verification for formulation dispensing
Obviousness Reasoning
Implementing access control for specialized formulations represents a standard technological enhancement using known authentication techniques
Source Patent Element
Cannabinoid formulation with multiple cannabinoid components
PTD Variation
Developing formulations for specific operational environments like disaster relief
Obviousness Reasoning
Tailoring drug compositions for specific scenarios is a routine application of pharmaceutical design principles with predictable results
Source Patent Element
Cannabinoid formulation with terpene profiles
PTD Variation
Adding environmental sensors to dynamically adjust formulation composition
Obviousness Reasoning
Integrating sensor technology for real-time formulation modification represents an obvious technological progression using standard control system design
Source Patent Element
Cannabinoid composition with multiple chemical components
PTD Variation
Creating portable kits with multiple pre-configured formulations for different conditions
Obviousness Reasoning
Developing modular pharmaceutical delivery systems with multiple configuration options is a standard approach in personalized medicine design
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857530 and the published technical disclosure, a person of ordinary skill in the art would find the claimed variations obvious, as they represent predictable extensions of existing cannabinoid formulation techniques through standard pharmaceutical design methodologies, technological integration, and environmental adaptation strategies.

Original Patent Information

Patent NumberUS 11,857,530
TitleCannabinoid formulations
Assignee(s)Endocanna Health, Inc.